1. Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (version 5.0). Australian Government Department of Health. 2016. http://www.pbac.pbs.gov.au/content/information/printable-files/pbacg-book.pdf . Accessed 15 Oct 2017
2. Belgian Guidelines for economic evaluations and budget impact analysis. KCE. 2015. https://kce.fgov.be/sites/default/files/page_documents/KCE_183_economic_evaluations_second_edition_Report.pdf . Accessed 15 Oct 2017.
3. Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. 4th ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2017. https://www.cadth.ca/dv/guidelines-economic-evaluation-health-technologies-canada-4th-edition . Accessed 15 Oct 2017.
4. National Institute for Health and Care Excellence (NICE). Single technology appraisal: user guide for company evidence submission template. 2015. https://www.nice.org.uk/process/pmg24/chapter/cost-effectiveness . Accessed 15 Oct 2017.
5. Haute Autorité de Santé (HAS). Choices in methods for economic evaluation. 2012. https://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf . Accessed 15 Oct 2017.